{"id":50827,"date":"2022-11-14T18:02:36","date_gmt":"2022-11-14T17:02:36","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\/"},"modified":"2022-11-14T18:02:36","modified_gmt":"2022-11-14T17:02:36","slug":"maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\/","title":{"rendered":"Maximus Awarded $100 Million Contract by the Centers for Disease Control and Prevention to Extend CDC-INFO Program"},"content":{"rendered":"
\n

\nMaximus to Leverage its Award-Winning Approach to Customer Experience to Expand CDC-INFO\u2019s Capabilities<\/i>\n<\/p>\n

TYSONS, Va.–(BUSINESS WIRE)–Maximus<\/a> (NYSE: MMS), a leading employer and provider of government services worldwide, today announced it had been awarded a contract for one base year plus four option years from the Centers for Disease Control and Prevention (CDC). Under the contract, which has an awarded value of $100 million over five years, Maximus will leverage its technology capabilities and operational improvement skills for the CDC-INFO program, which provides critical health information to millions of Americans.\n<\/p>\n

<\/a><\/p>\n

\n\u201cAt Maximus, we are motivated to help federal agencies overcome their biggest challenges, and there has been no greater challenge in our lifetime than the COVID-19 pandemic,\u201d said Teresa Weipert, General Manager, Federal Services, Maximus. \u201cWe are proud of what we\u2019ve accomplished with CDC and look forward to evolving the CDC-INFO program through the use of emerging technologies so the agency is prepared for whatever may come next.\u201d\n<\/p>\n

\nMaximus has supported the CDC-INFO program throughout the COVID-19 pandemic. This included the implementation of the National COVID-19 Vaccination Assistance Hotline (CDC-VAX) and its growth as the need for expertise surged. The success of the CDC-VAX program has led to multiple award wins for the agency and Maximus over the past year, including being honored in the 2022 Service to the Citizen Awards<\/a>.\n<\/p>\n

\nUnder the new contract period of performance, Maximus will make several digitally-enabled enhancements to improve communications of accurate, timely, and consistent health information to the public, providers, and federal partners. Using real-time data and call analytics to better identify trends, as well as track and improve customer satisfaction, Maximus is applying its proven approach to enhancing the Customer Experience on the CDC-INFO program.\n<\/p>\n

\n\u201cAgencies build trust with their constituents through excellent customer service and Maximus is uniquely positioned to ensure that interactions with CDC-INFO end with proper information being conveyed quickly and efficiently,\u201d said Lisa Slaughter, Senior Vice President, Maximus. \u201cThis CDC-INFO program will benefit from our experience serving millions of Americans through the CDC-VAX program, as we will focus on improving the user experience for those seeking information and effectively implement the technologies needed to make that happen.\u201d\n<\/p>\n

\nTo learn more about how Maximus has supported CDC during COVID-19, please visit this case study on the implementation and ongoing support of the CDC-VAX program: maximus.com\/case-study\/cdc-vax-helping-millions-get-vaccinated<\/a>.\n<\/p>\n

\nAbout Maximus
\n
<\/b>As a leading strategic partner to governments across the globe, Maximus helps improve the delivery of public services amid complex technology, health, economic, environmental, and social challenges. With a deep understanding of program service delivery, acute insights that achieve operational excellence, and an extensive awareness of the needs of the people being served, our employees advance the critical missions of our partners. Maximus delivers innovative business process management, impactful consulting services, and technology solutions that provide improved outcomes for the public and higher levels of productivity and efficiency of government-sponsored programs. For more information, visit maximus.com<\/a>.\u00a0\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor<\/b> Relations<\/b>
James Francis 703.251.8526
\n
Jessica Batt 703.251.8634
\n
IR@maximus.com<\/a><\/p>\n

Media & Public Relations<\/b>
Eileen Rivera 571.329.3410
\n
media@maximus.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Maximus to Leverage its Award-Winning Approach to Customer Experience to Expand CDC-INFO\u2019s Capabilities TYSONS, Va.–(BUSINESS WIRE)–Maximus (NYSE: MMS), a leading employer and provider of government services worldwide, today announced it had been awarded a contract for one base year plus four option years from the Centers for Disease Control and Prevention (CDC). Under the contract, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50827","6":"format-standard","7":"category-industry"},"yoast_head":"\nMaximus Awarded $100 Million Contract by the Centers for Disease Control and Prevention to Extend CDC-INFO Program - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Maximus Awarded $100 Million Contract by the Centers for Disease Control and Prevention to Extend CDC-INFO Program - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Maximus to Leverage its Award-Winning Approach to Customer Experience to Expand CDC-INFO\u2019s Capabilities TYSONS, Va.–(BUSINESS WIRE)–Maximus (NYSE: MMS), a leading employer and provider of government services worldwide, today announced it had been awarded a contract for one base year plus four option years from the Centers for Disease Control and Prevention (CDC). Under the contract, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-14T17:02:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221114005747\/en\/1449536\/21\/Maximus_logo_2022_med.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Maximus Awarded $100 Million Contract by the Centers for Disease Control and Prevention to Extend CDC-INFO Program\",\"datePublished\":\"2022-11-14T17:02:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\\\/\"},\"wordCount\":526,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221114005747\\\/en\\\/1449536\\\/21\\\/Maximus_logo_2022_med.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\\\/\",\"name\":\"Maximus Awarded $100 Million Contract by the Centers for Disease Control and Prevention to Extend CDC-INFO Program - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221114005747\\\/en\\\/1449536\\\/21\\\/Maximus_logo_2022_med.jpg\",\"datePublished\":\"2022-11-14T17:02:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221114005747\\\/en\\\/1449536\\\/21\\\/Maximus_logo_2022_med.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221114005747\\\/en\\\/1449536\\\/21\\\/Maximus_logo_2022_med.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Maximus Awarded $100 Million Contract by the Centers for Disease Control and Prevention to Extend CDC-INFO Program\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Maximus Awarded $100 Million Contract by the Centers for Disease Control and Prevention to Extend CDC-INFO Program - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\/","og_locale":"en_US","og_type":"article","og_title":"Maximus Awarded $100 Million Contract by the Centers for Disease Control and Prevention to Extend CDC-INFO Program - Pharma Trend","og_description":"Maximus to Leverage its Award-Winning Approach to Customer Experience to Expand CDC-INFO\u2019s Capabilities TYSONS, Va.–(BUSINESS WIRE)–Maximus (NYSE: MMS), a leading employer and provider of government services worldwide, today announced it had been awarded a contract for one base year plus four option years from the Centers for Disease Control and Prevention (CDC). Under the contract, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-14T17:02:36+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221114005747\/en\/1449536\/21\/Maximus_logo_2022_med.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Maximus Awarded $100 Million Contract by the Centers for Disease Control and Prevention to Extend CDC-INFO Program","datePublished":"2022-11-14T17:02:36+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\/"},"wordCount":526,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221114005747\/en\/1449536\/21\/Maximus_logo_2022_med.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\/","url":"https:\/\/pharma-trend.com\/en\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\/","name":"Maximus Awarded $100 Million Contract by the Centers for Disease Control and Prevention to Extend CDC-INFO Program - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221114005747\/en\/1449536\/21\/Maximus_logo_2022_med.jpg","datePublished":"2022-11-14T17:02:36+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221114005747\/en\/1449536\/21\/Maximus_logo_2022_med.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221114005747\/en\/1449536\/21\/Maximus_logo_2022_med.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/maximus-awarded-100-million-contract-by-the-centers-for-disease-control-and-prevention-to-extend-cdc-info-program\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Maximus Awarded $100 Million Contract by the Centers for Disease Control and Prevention to Extend CDC-INFO Program"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50827","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50827"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50827\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50827"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50827"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50827"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}